Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Rita Nanda"'
Autor:
Minoru Miyashita, Joshua S. K. Bell, Stephane Wenric, Ezgi Karaesmen, Brooke Rhead, Matthew Kase, Kristiyana Kaneva, Francisco M. De La Vega, Yonglan Zheng, Toshio F. Yoshimatsu, Galina Khramtsova, Fang Liu, Fangyuan Zhao, Frederick M. Howard, Rita Nanda, Nike Beaubier, Kevin P. White, Dezheng Huo, Olufunmilayo I. Olopade
Publikováno v:
Breast Cancer Research, Vol 25, Iss 1, Pp 1-13 (2023)
Abstract Background Endocrine-resistant HR+/HER2- breast cancer (BC) and triple-negative BC (TNBC) are of interest for molecularly informed treatment due to their aggressive natures and limited treatment profiles. Patients of African Ancestry (AA) ex
Externí odkaz:
https://doaj.org/article/006ca307fd264a2eaf4c46f5adf6c1f6
Autor:
Christos Vaklavas, Brian S. Roberts, Katherine E. Varley, Nancy U. Lin, Minetta C. Liu, Hope S. Rugo, Shannon Puhalla, Rita Nanda, Anna Maria Storniolo, Lisa A. Carey, Mansoor N. Saleh, Yufeng Li, Jennifer F. Delossantos, William E. Grizzle, Albert F. LoBuglio, Richard M. Myers, Andres Forero-Torres, on behalf of the Translational Breast Cancer Research Consortium (TBCRC)
Publikováno v:
Breast Cancer Research, Vol 22, Iss 1, Pp 1-15 (2020)
Abstract Background In preclinical studies, the expression of vascular endothelial growth factor (VEGF) in hormone receptor-positive breast cancer is associated with estrogen-independent tumor growth and resistance to endocrine therapies. This study
Externí odkaz:
https://doaj.org/article/5584ed790988432a9d02c709cacd449f
Autor:
Paolo A. Ascierto, Bruno Daniele, Hans Hammers, Vera Hirsh, Joseph Kim, Lisa Licitra, Rita Nanda, Sandro Pignata
Publikováno v:
Journal of Translational Medicine, Vol 15, Iss 1, Pp 1-21 (2017)
Abstract The complex interactions between the immune system and tumors lead the identification of key molecules that govern these interactions: immunotherapeutics were designed to overcome the mechanisms broken by tumors to evade immune destruction.
Externí odkaz:
https://doaj.org/article/62a141482a674e6d9a35a48c008c6805
Autor:
Brian S. Roberts, Andres Forero-Torres, Lisa A. Carey, Anna Maria Storniolo, Richard M. Myers, Nan Lin, Rita Nanda, Minetta C. Liu, Katherine E. Varley, Yufeng Li, Albert F. LoBuglio, Hope S. Rugo, Christos Vaklavas, Mansoor N. Saleh, William E. Grizzle, Jennifer F. Delossantos, Shannon Puhalla
Publikováno v:
Breast Cancer Research, Vol 22, Iss 1, Pp 1-15 (2020)
Breast Cancer Research : BCR
Breast Cancer Research : BCR
Background In preclinical studies, the expression of vascular endothelial growth factor (VEGF) in hormone receptor-positive breast cancer is associated with estrogen-independent tumor growth and resistance to endocrine therapies. This study investiga